[HTML][HTML] Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)

YY Qiu, J Zhang, FY Zeng, YZ Zhu - Pharmacological Research, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease phenotypes
which start with simple steatosis and lipid accumulation in the hepatocytes-a typical …

[HTML][HTML] Plants-based medicine implication in the evolution of chronic liver diseases

M Foghis, SG Bungau, AF Bungau, CM Vesa… - Biomedicine & …, 2023 - Elsevier
Hepatic disorders are considered major health problems, due to their high incidence,
increased risk of chronicling or death and the costs involved in therapies. A large number of …

Effects of the 5: 2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial

H Kord Varkaneh, A Salehi sahlabadi… - Frontiers in …, 2022 - frontiersin.org
Background and aims Dietary regimens are crucial in the management of non-alcoholic fatty
liver disease (NAFLD). The effects of intermittent fasting (IF) have gained attention in this …

New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk

K Yang, M Song - Nutrients, 2023 - mdpi.com
Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …

[HTML][HTML] Национальный Консенсус для врачей по ведению взрослых пациентов с неалкогольной жировой болезнью печени и ее основными коморбидными …

МВ Маевская, ЮВ Котовская, ВТ Ивашкин… - Терапевтический …, 2022 - cyberleninka.ru
Национальный мультидисциплинарный Консенсус подготовлен при участии
Национальной медицинской Ассоциации по изучению сочетанных заболеваний …

[HTML][HTML] Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists …

VT Ivashkin, MV Maevskaya, MS Zharkova… - Russian Journal of …, 2022 - gastro-j.ru
Aim: present clinical guidelines, aimed at general practitioners, gastroenterologists,
cardiologists, endocrinologists, comprise up-to-date methods of diagnosis and treatment of …

Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: A pilot double-blind, placebo …

F Naeini, Z Namkhah, H Tutunchi… - European Journal of …, 2022 - journals.lww.com
Objective Although several experimental models have suggested promising
pharmacological effects of naringenin in the management of obesity and its related …

The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities

M Maevskaya, Y Kotovskaya, V Ivashkin… - Terapevticheskii …, 2022 - ter-arkhiv.ru
Abstract The National Consensus was prepared with the participation of the National
Medical Association for the Study of the Multimorbidity, Russian Scientific Liver Society …

Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации …

ВТ Ивашкин, МВ Маевская, МС Жаркова… - Российский журнал …, 2022 - gastro-j.ru
Аннотация Цель: в клинических рекомендациях, предназначенных для врачей общей
практики, врачей-терапевтов, врачей-гастроэнтерологов, врачей-кардиологов, врачей …

[HTML][HTML] Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease

DV Garbuzenko - Gastroenterology and Hepatology from Bed to …, 2022 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease is one of the main liver diseases worldwide. The most
common cause of death in patients with nonalcoholic fatty liver disease is cardiovascular …